Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non–small‐cell...
Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non–small‐cell lung cancer (NEJ056)
About this item
Full title
Author / Creator
Furuta, Megumi , Horinouchi, Hidehito , Yokota, Isao , Yamaguchi, Teppei , Itoh, Shoichi , Fukui, Takafumi , Iwashima, Akira , Sugisaka, Jun , Miura, Yu , Tanaka, Hisashi , Miyawaki, Taichi , Yokouchi, Hiroshi , Miura, Keita , Saito, Ryota , Saito, Go , Kamoshida, Tatsuhiko , Uchinami, Yusuke , Kato, Tatsuya , Kobayashi, Kunihiko and Asahina, Hajime
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Locoregional recurrence of non–small‐cell lung cancer (NSCLC) after complete resection lacks standard treatment. Durvalumab after chemoradiotherapy (CRT) or CRT alone is often selected in daily clinical practice for patients with locoregional recurrence; however, the therapeutic efficacy of these treatments remains unclear, and we aimed to assess t...
Alternative Titles
Full title
Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non–small‐cell lung cancer (NEJ056)
Authors, Artists and Contributors
Author / Creator
Horinouchi, Hidehito
Yokota, Isao
Yamaguchi, Teppei
Itoh, Shoichi
Fukui, Takafumi
Iwashima, Akira
Sugisaka, Jun
Miura, Yu
Tanaka, Hisashi
Miyawaki, Taichi
Yokouchi, Hiroshi
Miura, Keita
Saito, Ryota
Saito, Go
Kamoshida, Tatsuhiko
Uchinami, Yusuke
Kato, Tatsuya
Kobayashi, Kunihiko
Asahina, Hajime
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11531949
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11531949
Other Identifiers
ISSN
1347-9032,1349-7006
E-ISSN
1349-7006
DOI
10.1111/cas.16340
